Dr. Michal Achmatowicz received Ph.D. in organic chemistry in 2001 after working with Prof. Janusz Jurczak at the University of Warsaw and the Institute of Organic Chemistry of the Polish Academy of Sciences in Warsaw, Poland. Until 2003 he was a postdoctoral research fellow with Prof. Louis S. Hegedus at Colorado State University. Subsequently, he joined Amgen’s Chemical Process R&D in Thousand Oaks, California, where he was involved in developing robust processes to traditional small molecules and hybrid-modality APIs for over 16 years. More recently, in 2020, he joined Mirati Therapeutics in San Diego to help establish the Chemical Process Group and lead the process development of early stage molecules.
: A new stereo-purification approach enabled by continuous flow-crystallization